European Diabetes Summit - 2026

We are pleased to invite you to the European Diabetes Summit – 2026, scheduled for 26–27 November in London, UK. As part of the World Diabetes Summit, this congress will bring together clinicians, endocrinologists, diabetologists, researchers, and industry leaders to share knowledge, present recent advances, and strengthen best practices in diabetes and endocrinology.

The meeting will focus on translating the latest research into practical clinical applications, highlighting evidence-based approaches and innovations that are shaping patient care and disease management. Attendees will benefit from interactive scientific sessions, real-world case discussions, and opportunities to connect and collaborate with experts and peers from across the globe.

We look forward to welcoming you to London for an inspiring and impactful scientific gathering dedicated to advancing the future of diabetes and endocrinology.

Sincerely,

Organizing Committee

European Diabetes Summit – 2026

A Subsidiary of the World Diabetes Summit

Scientific Tracks

The Scientific Committee of the European Diabetes Summit – 2026 is proud to present a comprehensive array of session topics designed to reflect current clinical challenges, translational research, and future innovations in the field.

• Advances in Type 1 and Type 2 Diabetes Management – Modern therapeutic strategies, combination treatments, and individualized glycemic targets.
• Innovations in Insulin Delivery and Glucose Monitoring – Smart insulin devices, continuous glucose monitors (CGM), and closed-loop systems.
• Gestational and Pediatric Diabetes – Diagnosis and management in children, adolescents, and during pregnancy.
• Endocrine Disorders and Hormonal Therapies – Updates on pituitary, adrenal, thyroid, and reproductive endocrine dysfunction.
• Obesity, Metabolic Syndrome, and Lipid Disorders – Medical, nutritional, and surgical approaches to weight and lipid regulation.
• Diabetic Complications and Comorbidities – Prevention and treatment of nephropathy, neuropathy, retinopathy, and cardiovascular risk.
• Endocrine Tumors and Oncology – Advances in diagnosis and targeted therapies for endocrine-related malignancies.
• Thyroid Dysfunction and Autoimmune Endocrinopathies – Clinical updates on hypothyroidism, hyperthyroidism, Hashimoto’s and Graves’ disease.
• Bone Health and Calcium Disorders – Osteoporosis, parathyroid conditions, and vitamin D-related bone metabolism.
• Artificial Intelligence and Digital Health in Endocrinology – Machine learning, digital therapeutics, and tele-endocrinology in clinical practice.
• Clinical Trials and Translational Research – Bridging the gap from bench to bedside with impactful clinical research

Submit Abstract

Authors are invited to submit abstract(s) using the submission form on this page. Abstracts should contain sufficient detail on the techniques used and the results, which will be shown. You will receive a confirmation when the abstract has been received. Please contact the conference secretariat if you did not receive confirmation within 5 working days.

Submission implies the intent of at least one author to register, attend the symposium and present the paper orally or in poster format. Contributions will only be finally accepted after registration and payment of the conference fee. The abstract will be reviewed, and you will be notified of acceptance.

Abstract Guidelines:

• The entire body of the abstract, excluding tables, must not exceed 250 words. Spaces are not included in this number. Title, authors’ names, affiliations, figures, and tables are not included in the character count.
• The abstract may be structured (i.e., abstracts divided into sections using terms such as Introduction, Methods, Results, Conclusions, etc.) or unstructured.
• Do not use bold type or underline formatting. Italic type is acceptable.
• Text may be in multiple paragraphs.
• Any references should be noted as citations within the text and not as footnotes at the end.

Important Dates

• 1st Phase Abstract Submission Deadline: 15th November, 2025
• Early Bird Registration Closes: 21st September, 2025

Focus of the Conference

The European Diabetes Summit – 2026, under the theme "Uniting Knowledge For Better Diabetes Care", is strategically designed to explore the most current, evidence-based, and clinically impactful developments in endocrinology and diabetology. The congress will provide a dynamic platform for deep scientific engagement, clinical insight, and translational innovation.

• Emerging Therapies in Diabetes Management:- Explore novel pharmacologic agents including dual and triple agonists (e.g., GLP-1/GIP receptor co-agonists), small-molecule insulin sensitizers, and oral semaglutide. Delve into personalized insulin therapy, beta-cell preservation strategies, and immune modulation in type 1 diabetes.
• Precision Endocrinology and Genomic Medicine:- Understand how genomics, epigenetics, and single-cell sequencing are redefining endocrine disease classification and enabling precision diagnosis and individualized therapy for thyroid disorders, adrenal pathologies, and genetic syndromes.
• Diabetes Technology and Digital Health:- Examine the clinical integration of advanced diabetes technologies such as automated insulin delivery systems (AID), continuous glucose monitoring (CGM), wearable biosensors, mobile health applications, and artificial intelligence for clinical decision support.
• Cardio-Renal-Metabolic Interventions:- Review the evolving role of SGLT2 inhibitors and GLP-1 receptor agonists in reducing cardiovascular events and renal progression in people with type 2 diabetes, as well as new agents targeting metabolic inflammation and lipotoxicity.
• Endocrine-Oncology and Rare Hormonal Disorders:- Explore innovations in the management of endocrine malignancies (thyroid cancer, adrenal tumors, pituitary adenomas), paraneoplastic syndromes, and rare genetic endocrine syndromes through a combination of molecular diagnostics and targeted therapies.
• Translational and Experimental Endocrinology:- Gain insight into bench-to-bedside research, including stem-cell derived islet transplantation, gene therapy for monogenic diabetes, and advances in endocrine disruptor science.
• Global Health, Health Equity & Chronic Disease Prevention:- Discuss the social and structural determinants of diabetes care, innovations in low-resource settings, and large-scale prevention programs addressing obesity, lifestyle, and environmental risks.
• Practical Skills and Real-World Case Studies:- Participate in hands-on workshops, multidisciplinary panel discussions, and live case-based sessions that emphasize the application of guidelines to daily practice, including management of diabetic foot, hyperglycemic crises, and endocrine emergencies.

The congress aims to translate scientific discovery into clinical excellence, preparing healthcare professionals and researchers to lead the next wave of innovation in diabetes care and endocrine health.

Who Should Attend

The European Diabetes Summit – 2026 invites participation from a diverse group of professionals involved in diabetes care, endocrinology research, and related healthcare sectors. The congress serves as a collaborative platform for knowledge exchange, skill enhancement, and global networking.

• Endocrinologists and Diabetologists – Specialists seeking the latest clinical updates and therapeutic advancements.
• Clinical Researchers and Translational Scientists – Professionals involved in experimental and applied endocrinology.
• Internal Medicine Physicians and General Practitioners – Clinicians managing chronic metabolic disorders in daily practice.
• Postgraduate Students, Fellows, and Residents – Emerging professionals aiming to deepen their expertise in endocrine science.
• Pharmaceutical and Biotechnology Industry Experts – Innovators focused on drug development, diagnostics, and medical devices.
• Nutritionists, Dieticians, and Lifestyle Therapists – Experts addressing diet and metabolic wellness in endocrine health.
• Nurses, Diabetes Educators, and Allied Health Professionals – Key partners in integrated diabetes and endocrine care delivery.
• Public Health Officials and Policy Makers – Stakeholders involved in healthcare systems, prevention strategies, and global health policy.